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EMERGING FROM THE SMOKE: DOES AN
EMPLOYER HAVE A DUTY TO ACCOMMODATE
AN EMPLOYEE’S MEDICAL MARIJUANA USE
AFTER GARCIA V. TRACTOR SUPPLY
COMPANY?
Lucía Morán*

INTRODUCTION
Imagine losing your job as a result of using a medicine prescribed to you by
your doctor. This is the situation Mr. Rojerio Garcia, an HIV positive patient enrolled
in the Medical Cannabis Program administered by the New Mexico Department of
Health,1 faced shortly after he was hired at a new job. Mr. Garcia disclosed to his
prospective employer during his initial interview both his medical condition and his
involvement in the Medical Cannabis Program.2 Nonetheless, once Mr. Garcia was
hired he was subjected to a drug test, and he was subsequently discharged after he
tested positive for cannabis metabolites.3 Finding no administrative remedy
available, Mr. Garcia brought suit against his employer alleging unlawful
discrimination under the Lynn and Erin Compassionate Use Act and the New Mexico
Human Rights Act.4
In cases like Mr. Garcia’s, the landscape of access to medical marijuana
remains increasingly hazy. On the federal level, marijuana is still classified alongside
drugs like heroin as a Schedule I illegal drug in the Controlled Substances Act, and
is defined as a drug “with no currently accepted medical use and a high potential for
abuse.”5 However, 29 states including Washington D.C. have passed laws legalizing
the use of marijuana for specific medical purposes, despite the fact that federal law
continues to criminalize marijuana distribution and possession.6 In New Mexico, the
Lynn and Erin Compassionate Use Act (“CUA”) allows medical marijuana
prescribed by a doctor to be available to patients with certain debilitating medical

* University of New Mexico School of Law, Class of 2018. Many thanks to my family, Rachel,
Victor, and Luna, and to my soulmate, Zack, for their constant love and support throughout. Also, thank
you to Professors Robert Desiderio and Walker Boyd, and to all of my colleagues at the New Mexico Law
Review who helped polish and shape this Note.
1.See NEW MEXICO DEPARTMENT OF HEALTH, GENERAL INFORMATION, https://nmhealth.org/
about/mcp/svcs/info/ (last visited Nov. 11, 2016).
2. Garcia v. Tractor Supply Co., 154 F.Supp.3d 1225, 1227 (D.N.M. Jan. 7, 2016).
3. Id.
4. Id.
5. Drug Scheduling, U.S. DRUG ENFORCEMENT AGENCY, https://www.dea.gov/druginfo/ds.shtml
(last visited Dec. 2, 2017).
6. National Conference of State Legislatures, State Medical Marijuana Laws, http://www.ncsl.org/
research/health/state-medical-marijuana-laws.aspx (last visited Dec. 2, 2017).
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conditions.7 While the CUA contains a provision that exempts doctors and patients
from criminal and civil penalties resulting from the medical use and possession of a
regulated amount of cannabis,8 important protections for employees participating in
the Medical Cannabis Program remain unresolved.
The question that lingers is, can the thousands of patients who use medical
marijuana in New Mexico9 and who are employed face adverse employment actions
because of that use, or must an employer accommodate an employee’s medical
marijuana use? If a doctor recommends a patient treat an illness with medical
marijuana, and the patient takes all the necessary administrative steps to register with
the Department of Health and comply with the doctor’s professional
recommendation, how can the patient’s medical use of marijuana be grounds for
employment termination? In Part I, this Comment looks briefly at the history of
medical marijuana and its purported medicinal value. Part I will also examine the
evolution and history of medical marijuana laws in New Mexico, and discuss the
decision by the New Mexican federal district court regarding medical marijuana and
employment accommodation in Garcia v. Tractor Supply Company.10
Part II will explore the questions posed by the Garcia decision and begin
by introducing the approaches to medical marijuana and employment
accommodation that other jurisdictions have adopted. It will then analyze why states
that prohibit an employer from discriminating against an employee with a medical
marijuana prescription is sound policy. Part II will also analyze why New Mexico
should adopt a similar approach. Part II will substantiate this analysis by exposing
inconsistencies between prior New Mexico Court of Appeals decisions dealing with
medical marijuana and compare them to the results of the Garcia case. It will then
briefly discuss the viability of testing impairment levels of an employee rather than
administering a standard drug test,11 thereby maintaining workplace safety while
respecting an employee’s need to treat an illness.
Part III will conclude that New Mexico should adopt the approaches
explored in Part II to deal with the ramifications of patients who use medical
marijuana and who are also employed. It will suggest that requiring employers to
accommodate employees with a valid medical marijuana prescription, so long as that
use does not interfere with job performance, would further both the plain language
and the intent of the Compassionate Use Act as well as the New Mexico Human
Rights Act, and would promote fairness and consistency within the law.

7. See N.M. STAT. ANN. 1978 § 26-2B-1 (2007).
8. Id. § 26-2B-4.
9. See NEW MEXICO DEPARTMENT OF HEALTH, MEDICAL CANNABIS PATIENT STATISTIC REPORT,
https://nmhealth.org/publication/view/report/3124/ (Sept. 30, 2016) (stating there are currently around
30,000 medical marijuana patients in New Mexico).
10. Garcia v. Tractor Supply Co., 154 F.Supp.3d 1225 (D.N.M. 2016).
11. See Stacy A. Hickox, Drug Testing of Medical Marijuana Users in the Workplace: An Inaccurate
Test of Impairment, 29 HOFSTRA LAB. & EMP. L. J. 273 (2012).
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I. BACKGROUND
A. The Evolving History of Medical Marijuana and the Law
The use of marijuana and its derivatives for medicinal purposes is rooted in
ancient historical practices. From its earliest inception as a medicinal tool, marijuana
was prescribed by physicians to treat a wide range of ailments including physical
pain and childbirth.12 Marijuana and hemp were also commonly prescribed by early
American physicians to address conditions like inflamed skin and incontinence.13
The practice of prescribing medical marijuana in the United States came to a crawl
when the Food and Drug Administration was created in 1906 to tackle the
population’s growing addition to morphine.14 Eventually, the Federal Government
criminalized the non-medical use of marijuana in 1937 after passing the Marihuana
Tax Act, and since then, harsher and harsher penalties for the use of marijuana have
been enacted.15 Only recently has public opinion in the states shifted back toward
acknowledging possible medical uses for marijuana, with 29 states and Washington
D.C. enacting local laws permitting the medical use of marijuana by qualifying
patients.16
New Mexico joined a state-led movement that recognized marijuana’s
potential for medical use during the 1970’s, when in 1978 the state initiated a medical
marijuana research program.17 It was not until 2007, however, that New Mexico
officially legalized the medical use of marijuana by certain patients under legislation
known as the Lynn and Erin Compassionate Use Act (“CUA”).18 The CUA was
designed and named in honor of Lynn Pierson and Erin Armstrong, both cancer
patients who advocated for access to marijuana for patients suffering from chronic
illnesses.19 This Act now allows for patients with a “debilitating medical condition”
like cancer, HIV/AIDS, glaucoma, epilepsy, and “any other medical condition . . .
approved by the department” to qualify for a medical marijuana permit.20 It also
exempts these patients and their prescribing doctors from all criminal and civil
penalties resulting from the regulated and approved use of medical marijuana to treat
the qualifying medical conditions.21

12. Patrick Stack & Claire Suddath, A Brief History of Medical Marijuana, TIME,
http://content.time.com/time/health/article/0,8599,1931247,00.html (Oct. 21, 2009).
13. Id.
14. Id.
15. Id.
16. National Conference of State Legislatures, State Medical Marijuana Laws,
http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx (last visited Dec. 2, 2107).
17. Scott C. Martin, A Brief History of Medical Marijuana Law in America, TIME,
http://time.com/4298038/marijuana-history-in-america/ (April 20, 2016).
18. See § 26-2B-1.
19. ABQJournal News Staff, 9:40am—Gov. Pushes Medical Marijuana Bill, ALBUQUERQUE
JOURNAL, Feb. 7, 2007, https://www.abqjournal.com/23857/940am-gov-pushes-medical-marijuanabill.html.
20. N.M. STAT. ANN. § 26-2B-3 (2007).
21. Id. § 26-2B-4.
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B. Marijuana and its Potential for Therapeutic and Medicinal Use
Marijuana’s continued classification as a Schedule I drug with no federally
recognized medical use makes it very difficult for scientists and doctors to officially
study and test it.22 Notwithstanding, limited studies have been done on cannabinoids,
chemical compounds found in the marijuana plant, which have in their individual
capacities been shown to relieve nausea, reduce pain and inflammation, and increase
appetite.23 Cannabinoids have also been known, mostly through personal anecdotes
and experiences rather than official clinical studies, to alleviate serious medical
conditions that other strong prescription drugs have not, including severe epilepsy in
children.24 Other chronic conditions that are difficult to treat with traditional
prescription drugs but that respond well to marijuana include cancer, post-traumatic
stress disorder, and neuropathic pain.25 However, due to the limited number of
official clinical studies and available data on the risks and benefits associated with
medical marijuana, the Food and Drug Administration has not approved it for sale
as a medicine.26
Despite the fact that the FDA has not approved marijuana as a medicine,
general attitudes towards its viability as such are shifting. In a recent study conducted
by the New England Journal of Medicine, doctors across North America were polled
about whether they would prescribe marijuana to a patient with certain medical
symptoms or conditions, and 76% said they would.27 This shifting perspective has
led to over a million estimated medical marijuana patients who hold valid permits
across the country.28 In New Mexico, the most current report indicates that over
45,000 patients are actively participating in the state’s medical cannabis program.29
The overwhelming majority of these patients use medical marijuana to treat posttraumatic stress disorder, severe chronic pain, and cancer.30
22. See When Weed Is The Cure: A Doctor’s Case for Medical Marijuana, NPR (July 14, 2015),
http://www.npr.org/sections/health-shots/2015/07/14/422876973/when-weed-is-the-cure-a-doctors-casefor-medical-marijuana.
23. NATIONAL
INSTITUTE
ON
DRUG
ABUSE,
MARIJUANA
AS
MEDICINE,
https://www.drugabuse.gov/publications/drugfacts/marijuana-medicine (July 2015).
24. See Kate Pickert, Pot Kids, TIME, http://time.com/pot-kids/ (2016).
25. See AMERICAN CANCER SOCIETY, MARIJUANA AND CANCER, http://www.cancer.org/
treatment/treatmentsandsideeffects/physicalsideeffects/chemotherapyeffects/marijuana-and-cancer
(March 4, 2015); see also When Weed Is The Cure: A Doctor’s Case for Medical Marijuana, NPR,
http://www.npr.org/sections/health-shots/2015/07/14/422876973/when-weed-is-the-cure-a-doctors-casefor-medical-marijuana (July 1, 2015).
26. See NATIONAL INSTITUTE ON DRUG ABUSE, MARIJUANA AS MEDICINE,
https://www.drugabuse.gov/publications/drugfacts/marijuana-medicine (July 2015).
27. Jonathan A. Adler & James A. Colbert, Medicinal Use of Marijuana—Polling Results, NEW
ENGLAND J. of MED., (May 30, 2013) (concluding that after polling 1,446 doctors of different specialties
from across the nation and abroad, a majority of doctors would prescribe medical marijuana to specific
patients).
28. PROCON.ORG, Number of Legal Medical Marijuana Patients (as of Mar. 1, 2016)
http://medicalmarijuana.procon.org/view.resource.php?resourceID=005889 (last visited Dec. 2, 2017).
29. NEW MEXICO DEPARTMENT OF HEALTH, MEDICAL CANNABIS PROGRAM PATIENT STATISTICS,
https://nmhealth.org/publication/view/report/4124/ (Nov. 30, 2017).
30. Id. The report indicates that the overwhelming majority of patients in New Mexico use medical
marijuana to treat post-traumatic stress disorder (22,097 people), severe chronic pain (15,016), and cancer
(2,701). Other listed conditions have fewer registered patients.
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C. The case of Garcia v. Tractor Supply Company
Rojerio Garcia was one of the thousands of patients in New Mexico
lawfully using medical marijuana to treat the symptoms of his debilitating medical
condition.31 He was participating in the state’s medical cannabis program and using
marijuana prescribed by his doctor to treat his condition when he applied for a
managerial job with Tractor Supply Company.32 Mr. Garcia disclosed his medical
status and participation in the medical cannabis program to the company during his
initial interview.33
Mr. Garcia was subsequently hired and required to undergo a drug test,
which came back positive for cannabis metabolites.34 Due to this drug test result, Mr.
Garcia’s employment was terminated by Tractor Supply Company.35 Mr. Garcia,
after exhausting the available administrative remedies, brought suit in state court
against the company alleging wrongful and discriminatory employment
termination.36 Tractor Supply Company successfully removed the case to federal
court where it was dismissed for failure to state a claim upon which relief could be
granted.37
The United States District Court for the District of New Mexico held that
Mr. Garcia did not have a cause of action under the Lynn and Erin Compassionate
Use Act and the New Mexico Human Rights Act because his employer had no duty
to accommodate his medical marijuana use.38 The issues of medical marijuana use
and employment accommodation were issues of first impression in New Mexico.39
The court found that because neither the Compassionate Use Act nor the New
Mexico Human Rights Act contains explicit language mandating an employer
accommodate an employee’s medical marijuana use, such a duty to accommodate
cannot be inferred from these statutes and imposed on employers by the court.40
In addition, the court held that Mr. Garcia did not have a cause of action
under the New Mexico Human Rights Act because he was not discriminated against
or terminated due to his serious medical condition.41 The court separated Mr.
Garcia’s illness from his treatment, and reasoned that “[t]esting positive for
marijuana was not because of Mr. Garcia’s serious medical condition (HIV/AIDS),
nor could testing positive for marijuana be seen as conduct that resulted from his
serious medical condition. Using marijuana is not a manifestation of HIV/AIDS.”42

31. See Garcia v. Tractor Supply Co., 154 F.Supp.3d 1225, 1226 (D.N.M. 2016).
32. Id. at 1227.
33. Id.
34. Id.
35. Id.
36. Id.
37. Id. at 1227, 1230.
38. Id. at 1229; see also, N.M. STAT. ANN. 1978, Ch. 28, Art. 1 (2017); N.M. STAT. ANN. 1978, Ch.
26, Art. 2B (2017).
39. Garcia, 154 F.Supp.3d at 1227.
40. Id. at 1227, 1229.
41. Id. at 1228.
42. Id.
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The court relied primarily on how other states have handled issues of
medical marijuana use and employment accommodation to reach the conclusion that
the New Mexico Human Rights Act did not provide Mr. Garcia with a cause of
action. The court found a Colorado case instructive, and explained that while an antidiscrimination law protects an employee with a disability from adverse employment
actions, it does not protect the employee from an “employer’s standard policies
against employee misconduct. In other words, a termination for misconduct is not
converted into a termination because of a disability just because the instigating
misconduct somehow relates to a disability.”43
Additionally, the court found that requiring a company with branches in
many other states to accommodate an employee’s marijuana use would present too
great a burden because the company would have to alter its workplace drug policies
depending on which state law applied.44 Adding to this point, the court concluded its
judgement by addressing the conflicts presented by the Controlled Substance Act
(“CSA”) and the CSA’s preemption of state law. The court reasoned that mandating
an employer to accommodate a worker’s medical marijuana use would effectively
be akin to asking the employer to accommodate conduct strictly prohibited under the
CSA.45 Specifically, the court stated that because marijuana is an illegal drug
federally, requiring an employer to be aware of an employee’s use and to
accommodate it would require the employer to “permit the very conduct the CSA
proscribes.”46 Thus, the court granted Tractor Supply Company’s motion to dismiss
and held that an employer does not have a duty to accommodate an employee’s
medical marijuana use under either the Compassionate Use Act or the New Mexico
Human Rights Act.47
II. ANALYSIS
The Garcia court’s ruling leaves two major questions largely unresolved.
First, did the court correctly find that employees who use medical marijuana do not
have a cause of action for wrongful and discriminatory termination under the
Compassionate Use Act and the New Mexico Human Rights Act? The second
question that the ruling invites is whether the court correctly applied the provisions
of the Controlled Substances Act to the issue of accommodation, and whether the
CSA presents a conflict for employers if they are required to accommodate an
employee’s medical marijuana use.
A. The States Divided: Three Different Approaches to Employment and
Medical Marijuana
The federal district court in Garcia failed to find that an employer has a
duty to accommodate an employee’s medical marijuana use due in large part to
marijuana’s federal classification as an illegal substance and the unreasonable burden

43.
44.
45.
46.
47.

Id. (quoting Curry v. MillerCoors, Inc., 2013 WL 4494307, at *3 (D.Colo. Aug. 21, 2013)).
Id. at 1229.
Id. at 1230.
Id.
Id. at 1226, 1228.
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such an accommodation would place on a company with locations nationwide.48 The
court, in reaching this conclusion, relied on the interpretation of similar statutes by
courts in other jurisdictions.49
Generally, there are three different approaches that states use to deal with
the intersection of employment accommodation and medical marijuana use.50
Several states have chosen to include explicit anti-discrimination clauses directly in
the medical cannabis statute, preventing employers from taking adverse employment
action against an employee based solely on medical marijuana use.51 One state has
not only enacted anti-discrimination clauses, but has also classified a medical
marijuana patient as having a recognized disability under the state’s Human Rights
Act.52 Normally, reasonable accommodation provisions require an employer to
accommodate medical marijuana use after making a holistic determination of the
nature of the job and any possible accommodations that could be offered to help the
employee successfully manage those duties.53These provisions provide an exception
to the duty to accommodate if doing so would compromise the safety of the worker
or another person.54 Typically, this exception for “safety-sensitive” employment
positions is invoked when the job involves driving, operating heavy machinery, or
other high risk activities.55 Also, anti-discrimination provisions do not allow the
employee to be intoxicated while at work or to use marijuana on the jobsite or in a
public place.56
Arizona is one such state that has chosen to prohibit discrimination against
employees lawfully complying with the state-run medical cannabis program.57 Under
the Arizona Medical Marijuana Act, an “employer may not discriminate against a
person in hiring, termination or imposing any term or condition of employment or

48. Id. at 1229, 1230.
49. Id. at 1230.
50. See Francesca Liquuori, National Attorneys General Training and Research Institute, The Effects
of Marijuana Legalization on Employment Law, 1 NAGTRI J. 2 (Feb. 18, 2016), http://www.naag.org/
publications/nagtri-journal/volume-1-number-2/the-effects-of-marijuana-legalization-on-employmentlaw.php.
51. Arizona, Arkansas, Connecticut, Delaware, Illinois, Maine, Minnesota, Nevada, New Jersey
(anti-discrimination bills pending at this time), New York, Pennsylvania, and Rhode Island are the
jurisdictions that have incorporated protections for employees using medical marijuana during non-work
hours. Dale L. Deitchler, The Workplace and Medical Marijuana: Employer Guidelines for Navigating
the Legal Haze, INSIDE COUNSEL (Apr. 15, 2015), http://www.insidecounsel.com/2015/04/15/theworkplace-and-medical-marijuana-employer-guide; M. Tae Phillips and Michael J. Riccobono, New
Jersey Bill Would Provide Employment Protections for Medical Marijuana Patients, SOCIETY FOR
HUMAN RESOURCE MANAGEMENT (Apr. 11, 2017), https://www.shrm.org/resourcesandtools/legal-andcompliance/state-and-local-updates/pages/new-jersey-bills-would-provide-medical-marijuanaemployment-protections.aspx.
52. N.Y. PUBLIC HEALTH LAW §3369(2) (McKinney 2017).
53. See Liquuori, supra note 50.
54. See id; see also Kathleen Harvey, Protecting Marijuana Users in the Workplace, 66 CASE W.
RES. L. REV. 209 (2015).
55. Deitchler, supra note 51.
56. Id.
57. Joseph A. Yastrow, A Survey of Medical Marijuana Laws Impacting the Workplace (2015),
http://www.americanbar.org/content/dam/aba/events/labor_law/am/2015/yastrow.authcheckdam.pdf.
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otherwise penalize a person based upon” that person’s status as a medical marijuana
patient or that person’s positive drug test indicating medical marijuana use.58
The confines of accommodation are strictly defined, however, and the
employer is not required to accommodate the use of medical marijuana during work
hours or in the workplace.59 The anti-discrimination clause in the Arizona Medical
Marijuana Act protects employees from termination or other employment
discrimination based solely on authorized medical marijuana use, but still gives
employers enough control to ban marijuana use from the workplace and from highrisk jobs. The anti-discrimination statute requires employers to engage in a more
nuanced analysis of the employee’s medical marijuana use, specifically “whether
the . . . employee is lawfully enrolled in the state’s medical marijuana program,
whether the level of cannabis shown on the [drug] test is consistent with such use,
and whether there is a job-related reason that a medical marijuana user could not be
hired. . . . “60 Absent a showing of high-risk job duties, intoxication, or marijuana
use on the jobsite, an employee cannot be terminated solely for medical marijuana
use.61
Minnesota’s THC Therapeutic Research Act, much like Arizona’s Medical
Marijuana Act, contains a specific provision protecting registered patients of the
state’s cannabis program from a range of civil penalties, including adverse
employment consequences due to medical marijuana use.62 As in Arizona, an
employee cannot be terminated under Minnesota’s statute solely based on a positive
drug test showing cannabis metabolites.63 Instead, the employer must determine
whether the employee’s marijuana use impairs the employee’s ability to perform job
duties.64 Minnesota also gives employees the opportunity to explain drug test results
that come back positive before an employer can take any adverse action, and if the
employee is a registered cardholder, the employee cannot be terminated on the basis
of a positive drug test alone.65 These provisions are substantially similar to those in
Arizona’s Medical Marijuana Act because they are intended to protect workers from
arbitrary discrimination based on legal medical marijuana use, while at the same time
allowing employers to take medical marijuana use into consideration when safety is
a concern.
New York takes this approach one step further by classifying a medical
marijuana patient as technically having a disability under the New York Human

58. ARIZ. REV. STAT. ANN. § 36-2813(B) (2010).
59. Id. § 36-2813(B)(2).
60. Hunton & Williams LLP, Anti-Discrimination Provisions in State Medical Marijuana Laws
Raise Additional Considerations for Workplace Drug Testing, HUNTON EMPLOYMENT AND LABOR LAW
PERSPECTIVES (Jan. 22, 2015), http://www.huntonlaborblog.com/2015/01/articles/criminal-backgroundchecks/antidiscrimination-provisions-in-state-medical-marijuana-laws-raise-additional-considerationsfor-workplace-drug-testing/.
61. Id.
62. See MINN. STAT. §152.32(3)(c) (2014).
63. See Hunton & Williams, supra note 60.
64. MINN. STAT. §152.32(3)(c)(2) (2014).
65. Id.; §181.953(6)(b) (2004).
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Rights Act.66 Classifying medical marijuana patients as automatically having a
disability means an employer must accommodate the employee’s disability that
necessitates marijuana use and the use itself as one and the same, and not as separate,
unrelated entities.67 Nevertheless, like in other jurisdictions with anti-discrimination
or accommodation requirements, an employer in New York is not obligated to
accommodate on-the-job intoxication or use.68
Anti-discrimination laws like those in New York, Arizona, and Minnesota
likely create a direct cause of action for the employee facing discrimination
stemming from medical marijuana use.69 Creating such a cause of action ensures the
enforcement of anti-discrimination provisions and treats both the medical condition
and the means of treatment, marijuana, as a private affair that need not interfere with
employment so long as that treatment does not affect job performance or jeopardize
workplace safety.
The trend set by states like Arizona, Minnesota, and New York towards
accommodation for medical marijuana patients and employees is growing. New
Jersey, like many other states that have legalized medical marijuana but have yet to
address employment issues, is taking another look at its statute and moving towards
enacting anti-discrimination provisions to protect employees using medical
marijuana.70 Currently, the New Jersey Compassionate Use Act provides no
protection or direct cause of action for employees facing discriminatory hiring
practices, but that could soon change.71 In February 2016, a bill was introduced that
would bring New Jersey in line with states like Minnesota and amend the New Jersey
Compassionate Use Act to prohibit employers from terminating employees based
solely on medical marijuana use.72 This bill was a response to the growing litigation
surrounding the New Jersey Compassionate Use Act and employers’ refusal to
accommodate employee’s medical marijuana use.73
In fact, New Jersey’s proposed anti-discrimination provisions or reasonable
accommodation requirements seem to be an emerging nationwide trend. For
instance, Pennsylvania’s newly enacted state-run medical marijuana program has

66. N.Y. Public Health Law §3369(2) (McKinney 2017); see also Sharon P. Stiller, AntiDiscrimination Statutes, 13A N.Y. PRAC, EMPLOYMENT LAW IN NEW YORK § 4:160.50 (2d ed.) (last
updated Nov. 2017).
67. Stiller, supra note 66.
68. See Kathleen Harvey, Protecting Marijuana Users in the Workplace, 66 CASE W. RES. L. REV.
209 (2015).
69. See N.Y. PUBLIC HEALTH LAW §3369 (McKinney 2017); ARIZ. REV. STAT. ANN. § 362813(B) (2010); MINN. STAT. §152.32(3)(c) (2014).
70. See Ivo Becica, Up In Smoke – Are Employers Required to Accommodate Medical Marijuana
Use?, HR LEGALIST (Apr. 20, 2016), http://www.hrlegalist.com/2016/04/up-in-smoke-are-employersrequired-to-accommodate-medical-marijuana-use/.
71. See N.J. STAT. ANN. §24:6I-14 (2010); see also, Becica, supra note 70
72. Becica, supra note 70.
73. See, Susan K. Livio, NJ Transit Sued for Suspending Employee in Medical Marijuana Program,
NJ.COM, Apr. 4, 2014, http://www.nj.com/politics/index.ssf/2014/04/nj_transit_sued_for_suspending_
employee_in_medical
_marijuana_program.html (describing problems that arise when employees who are also medical
marijuana patients are not afforded accommodations at work and the lawsuits that result).
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adopted an explicit anti-discrimination protection for employees.74 These two states
will join a growing list of jurisdictions that provide for anti-discrimination
protections in the workplace.75 As more and more states pass bills legalizing the use
of marijuana for medical purposes, they will have to consider the ramifications for
employment that come with this legalization. Choosing to address employment
issues directly in the statutes provides clear guidance for employers as to the
expectations that come with this new treatment as well as protection for employees
who participate in the cannabis program.76
Many of the remaining states that have medical marijuana programs
approach medical marijuana and employment law like Garcia did, holding that an
employer has no duty to accommodate an employee’s medical marijuana use because
such accommodation would directly conflict with federal law and is not mandated
by state statute.77 This approach jeopardizes medical marijuana patients who are
employed, and disregards state law that recognizes marijuana as a viable medicine.
Additionally, accommodating an employee’s medical marijuana use does not require
an employer to accommodate drug use outside the tight confines of legal medical
marijuana. States with medical cannabis programs all narrowly restrict the
boundaries of marijuana use, and none permit employees to work while intoxicated
or to use marijuana in public places. Participants in medical cannabis programs are
also thoroughly screened and must comply with the directives of the state health
department.78
Implementing a test to monitor an employee’s level of impairment rather
than a standard drug test would serve as an added protection for employers who
accommodate an employee’s medical marijuana use.79 Preliminary research has
shown that marijuana, when used correctly for health reasons as opposed to
recreationally, generally has little effect on work-performance.80 Standard drug
testing is a limited means to detect impairment because it only reveals the presence
of cannabis metabolites, which can enter the body and linger in a person’s system

74. PA. STAT. § 10231.2103(b)(1) (2016).
75. Currently, states with medical marijuana statutes that contain anti-discrimination clauses or
protections for participating employees include Arizona, Arkansas, Connecticut, Delaware, Illinois,
Maine, Minnesota, Nevada, New York, Pennsylvania, and Rhode Island. Yastrow, supra note 57. See
also, The Arkansas Medical Cannabis Act, Section 103(f)(3). The states with anti-discrimination
protections for employees constitute almost half of all states which have legalized medical marijuana.
76. The medical marijuana bill recently enacted in Arkansas in 2016 contains an anti-discrimination
clause that would protect workers using physician prescribed medical marijuana from employment
discrimination. ARK. CONST. AMEND. 98, § 3.
77. See, e.g, Emerald Steel Fabricators Inc. v. Bureau of Labor and Indus., 230 P.3d 518, 536 (Or.
2010) (holding that the Oregon Medical Marijuana Act did not require an employer to accommodate an
employee’s medical marijuana use because such use is illegal under the Controlled Substances Act);
Coates v. Dish Network, LLC, 350 P.3d 849, 853 (Colo. 2015) (holding an employee can be terminated
as a result of medical marijuana use because such use is not “lawful activity” under federal law); Ross v.
Ragingwire Telecomms., Inc., 174 P.3d 200, 203 (Cal. 2008) (holding an employer did not have to
accommodate an employee’s “illegal drug use”).
78. Deitchler, supra note 51.
79. See Stacy A. Hickox, Drug Testing of Medical Marijuana Users in the Workplace: An Inaccurate
Test of Impairment, 29 HOFSTRA LAB. & EMP. L. J. 273 (2012).
80. Id. at 290.
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for up to four weeks after being ingested.81 Tests measuring levels of impairment
rather than the presence of cannabis metabolites have proven to be more effective at
preventing accidents and improving workplace safety than standard drug testing
alone.82 Low cost alternatives to traditional drug tests that have already been
implemented and that have successfully monitored an employee’s level of
impairment include direct observation of an employee’s behavior, “requiring . . . an
employee keep a cursor on track during a computer simulation, or . . . evaluation of
eye movements.”83
B. The New Mexico Court of Appeal’s Workers’ Compensation Decisions and
Repercussions
While New Mexico state courts have not yet ruled on the issue of medical
marijuana and employment discrimination, the New Mexico Court of Appeals has
decided three significant cases dealing with medical marijuana and workers’
compensation. These decisions are pivotal because they could control the outcome
of any future litigation involving medical marijuana and employment
accommodation. For example, in Vialpando v. Ben’s Automotive Services, Lewis v.
American General Media, and Maez v. Riley Industrial, the New Mexico Court of
Appeals consistently found medical marijuana to be a necessary medical treatment
compensable under the Lynn and Erin Compassionate Use Act and the Workers’
Compensation Act.84
In Vialpando, an employee was injured on the job and suffered excruciating
pain resulting from the injury.85 The employee applied for workers’ compensation to
participate in the physician certified medical marijuana program due to the severe
level of pain he was experiencing that was not successfully controlled by strong
narcotics.86 The Workers’ Compensation Judge found that the worker was “entitled
to ongoing and reasonable medical care” and approved the application for medical
marijuana.87 The employer appealed to the Court of Appeals.88
The Court of Appeals found that not only was medical marijuana a
“reasonable and necessary health care service,” but also that a certification to the
state-run medical marijuana program issued by a physician was “the functional
equivalent of a [medical] prescription.”89 The Court of Appeals also focused on the
intent behind the enactment of the Lynn and Erin Compassionate Use Act, which
was for medical marijuana to be easily accessible to those who qualify for it. 90 The
court recognized that allowing for medical marijuana to be compensable under the
81. See id. at 301.
82. See id. at 306.
83. Id. at 305.
84. Vialpando v. Ben’s Automotive Services, 2014-NMCA-084, 331 P.3d 975; see also, Lewis v.
Am. Gen. Media, 2015-NMCA-090, 355 P.3d 850; Maez v. Riley Indus., 2015-NMCA-049, 347 P.3d
732.
85. Vialpando, 2014-NMCA-084, ¶ 2.
86. Id. ¶ 3.
87. Id. ¶ 4 (internal quotation marks omitted).
88. Id.
89. Id. ¶¶ 13–14.
90. Id. ¶ 13 (quoting the Lynn and Erin Compassionate Use Act, § 26-2B-2).
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Workers’ Compensation Act furthered the legislative intent of the CUA because it
“allow[ed] [for] the beneficial use of medical cannabis in a regulated system for
alleviating symptoms caused by debilitating medical conditions.”91
This decision finding medical marijuana to be both a reasonable and
necessary medical treatment under workers’ compensation was echoed and
reaffirmed again by the Court of Appeals in later decisions. In Maez v. Riley
Industrial, the Court of Appeals held that the worker’s attending doctor “adopted a
treatment plan that called for medical marijuana. By the very nature of such
treatment, medical marijuana was a necessary” medical treatment, as deemed by the
worker’s doctor, and thus was a legitimate, physician approved treatment plan that
should be accorded the same deference as any other prescription medicine.92
Similarly, the Court of Appeals held again in Lewis v. American General
Media that medical marijuana is a reasonable and necessary medical treatment and
is compensable under workers’ compensation.93 The professional opinions of the
worker’s doctors recommending that the worker treat symptoms of debilitating pain
with medical marijuana was given deference.94 The court found marijuana to be
compensable, reasonable, and necessary to the worker’s medical treatment on this
basis and the plain language and legislative intent of the Compassionate Use Act.95
C. The Best Approach for New Mexico: Untangling the Garcia Case
1. Distinguishing an illness from its medicine
The Garcia Court held that an employer has no duty to accommodate an
employee’s medical marijuana use. The court reached this conclusion in part by
relying on the Curry case and its interpretation of the rights owed to an employee
under the Colorado medical cannabis statute.96 By adopting this approach to medical
marijuana and employment accommodation, the Court chose to separate the illness
from the treatment. The Court chose to distinguish two inextricably linked concepts
and decided that an employee could be terminated based on one, the medicine, but
not the other, the illness that causes the need for the medicine. Yet, the illness
unquestionably necessitates the medicine, and to separate the two is to misunderstand
the dynamics of health, to undercut the rights of a patient in choosing a treatment
plan, and to dismiss the laws of the state.
This careful parsing of employment termination on the basis of a medicine
and not an illness is inconsistent with the intent of the Lynn and Erin Compassionate
Use Act and the New Mexico Human Rights Act. These Acts and their intent are
comparable on the federal level to the Americans with Disabilities Act (“ADA”). For
instance, the Equal Employment Opportunity Commission, the agency responsible
for enforcing the ADA, has brought claims on behalf of employees whose only

91.
92.
93.
94.
95.
96.

Id. (quoting the Lynn and Erin Compassionate Use Act, § 26-2B-2).
Maez v. Riley Indus., 2015-NMCA-049, ¶ 27, 347 P.3d 732.
Lewis v. Am. Gen. Media, 2015-NMCA-090, ¶ 2, 355 P.3d 850.
See id. ¶ 20.
See id. ¶ 32.
Garcia v. Tractor Supply Co., 154 F.Supp.3d 1225, 1228 (D.N.M 2016).
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indication of a disability has been the use of a prescription drug.97 These non-obvious
disabilities, such as mental illness, epilepsy, HIV/AIDS, and others, are still
considered disabilities within the meaning of the ADA and are often only detectable
through their prescription medication treatments, as they usually display no
noticeable outward signs or symptoms.98 At the state level, the New Mexico Court
of Appeals has already held that medical marijuana is a necessary and reasonable
medical treatment. It is likely, therefore, that the New Mexico Human Rights Act
would protect not only the serious medical condition, but also its reasonable and
necessary treatment as defined by the Court of Appeals.
Thus, the similarities between the New Mexico Human Rights Act and the
ADA are worth acknowledging and briefly exploring. Employers who terminate
employees based on the prescription medicine used to treat a disability violate the
ADA non-discrimination requirement.99 Similarly, the New Mexico Human Rights
Act prohibits an employer from discriminating against an employee based on a
medical condition.100 Just as specified under both the ADA and the New Mexico
Human Rights Act, an employee cannot be terminated based on a disability and the
enforcement of the ADA has often equated a disability or illness with its treatment.101
It is possible to infer that the New Mexico Human Rights Act is intended to protect
people with serious medical ailments from discrimination, and that protection also
extends to the medicine used to treat the illness, especially after the rulings by the
New Mexico Court of Appeals which found medical marijuana to be a reasonable
and necessary medical treatment.
The Court in Garcia set a tricky precedent when it reasoned that Mr.
Garcia’s employment was legitimately terminated due to his medical marijuana use
and not due to his serious medical condition. A patient who wishes to participate in
the New Mexico Medical Cannabis Program has difficult obstacles to clear, contrary
perhaps to popular belief. The patient must have a recognized qualifying medical
condition which must be both “chronic and debilitating,” and demonstrate that
“standard medical treatments have failed to provide adequate relief” and that the
“benefits of using medical cannabis outweigh the detrimental side effects.”102 The
patient must then successfully navigate through lengthy bureaucratic steps so that

97. See U.S. EQUAL EMPLOYMENT OPPORTUNITY COMMISSION, Press release: Dura Automotive
Systems to Pay $750,000 to Settle EEOC ADA Lawsuit (Sept. 5, 2012),
https://www1.eeoc.gov/eeoc/newsroom/release/9-5-12.cfm; see also, U.S. EQUAL EMPLOYMENT
OPPORTUNITY COMMISSION, Dayton Superior Corporation to Pay $50,000 to Settle EEOC Disability
Discrimination Lawsuit (Jan. 4, 2013), https://www1.eeoc.gov/eeoc/newsroom/release/1-4-13a.cfm.
98. The Americans with Disabilities Act, 42 U.S.C. § 12102 (2009).
99. Id. § 12112.
100. N.M. STAT. ANN. 1978, § 28-1-7(A) (2004).
101. U.S. EQUAL EMPLOYMENT OPPORTUNITY COMMISSION, ENFORCEMENT GUIDANCE:
DISABILITY RELATED INQUIRIES AND MEDICAL EXAMINATIONS OF EMPLOYEES UNDER THE AMERICANS
WITH DISABILITIES ACT (ADA) (B)(1) (March 4, 2005), https://www.eeoc.gov/policy/docs/guidanceinquiries.html (defining a “disability-related inquiry” and likely prohibiting under the ADA questions
such as: “asking an employee whether s/he currently is taking any prescription drugs or medications,
whether s/he has taken any such drugs or medications in the past, or monitoring an employee’s taking of
such drugs or medication.”)
102. ZIA HEALTH AND WELLNESS MEDICAL CANNABIS PROGRAM, FAQ (2016),
https://www.medicalcannabisprogram.com/mmj/medical-marijuana-program-faq.
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the patient’s participation in the program is adequately overseen and monitored by
the New Mexico Department of Health.103
In these ways, the process to obtain a medical marijuana prescription is
much more rigorous than the process to obtain the average prescription medicine.104
Without a qualifying serious medical condition, of which there is a list, a patient
cannot be accepted into the Medical Cannabis Program. The Court, in deciding Mr.
Garcia’s employment was terminated for marijuana use and not for his serious
medical condition, chose to ignore the fact that without the medical condition, Mr.
Garcia would not have a medical marijuana card. The court also stunted the intent
and the reach of the Lynn and Erin Compassionate Use Act, which was enacted so
that patients could, with the guidance of their physician, choose a treatment plan that
included medical marijuana. This intent is strengthened by the New Mexico Human
Rights Act, which gives patients the security of knowing that they cannot be
terminated or discriminated against based on their disability or illness. From the
intent of the Compassionate Use Act and from the New Mexico Court of Appeals
decisions regarding medical marijuana, it follows that the New Mexico Human
Rights Act protects not only the serious medical condition from discrimination, but
the method of treatment as well.
Medical marijuana is legally available under New Mexico state law for
qualifying patients, and the debate about whether an employer must accommodate
an employee’s doctor-prescribed use should end there. In keeping with the intent of
the Compassionate Use Act, the New Mexico Human Rights Act, and the New
Mexico Court of Appeals decisions, a person’s medical treatment should remain a
personal decision between the patient and the doctor. Compelling an employer to
accommodate an employee’s medical marijuana use would mean only that the
employer cannot terminate an employee solely based on the legal treatment the
employee has chosen. In this regard, accommodation of medical marijuana would
maintain a clear separation between an employer and an employee’s personal
medical decisions, and would be in line with the intent of the Compassionate Use
Act, the New Mexico Human Rights Act, and the New Mexico Court of Appeals
decisions.
Accommodation would in no way require an employer to allow an
employee to use medical marijuana on the job-site or during work hours, or allow an
employee to work while intoxicated.105 Instead, accommodation would only mean
that if an employee choses to treat a serious medical condition with medical
marijuana during non-work hours, and that use does not interfere with the
employee’s job performance, then medical marijuana should not be a factor in
employment decisions. The Garcia Court, in ruling that the employee was

103. See id.
104. See NATIONAL INSTITUTES OF HEALTH, Getting a Prescription Filled (Aug. 1, 2015),
https://medlineplus.gov/ency/article/001956.htm (describing how to obtain a prescription medicine,
which typically consists of seeing a doctor and filling the prescription at a pharmacy).
105. No state that requires employers to accommodate employee medical marijuana use requires
accommodation of on-the-job marijuana use or visible intoxication. See, G.M. Filisko, Employers and
Workers Grapple With Laws Allowing Medical Marijuana Use, ABA JOURNAL (Dec. 1, 2015),
http://www.abajournal.com/magazine/article/employers_and_workers_grapple_with_laws_allowing_ma
rijuana_use/ (last visited Dec. 17, 2017).
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terminated due to his medical treatment and not his medical condition, gave the
employer a say in the employee’s private medical decisions. This decision not only
gives an employer undue influence over an employee’s private medical decision, but
is also contrary to the intent and plain language of the New Mexico Human Rights
Act, the Lynn and Erin Compassionate Use Act, and the controlling New Mexico
Court of Appeals decisions.
2. Can an employer face penalties for an employee’s medical marijuana
use?
The next consideration that must be addressed if employers are to
accommodate an employee’s medical marijuana use is whether the employer can
face any legal repercussions for that accommodation. One area of concern for
employers could stem from the Drug Free Workplace Act. The Drug Free Workplace
Act requires employers who wish to contract with or receive grants from the federal
government to comply with specific conditions.106 However, employers are not
required to administer drug tests to their employees or report the results of drug tests
in order to meet the requirements of the Drug Free Workplace Act.107 The only
requirements imposed on employers to keep federal grants or contracts is to make
employees aware that the workplace is drug-free, meaning no drug-use is permitted
on-site and that adverse action can be taken against an employee who does not
comply with this policy.108 The Act makes no mention or prohibition of an
employee’s at-home use of a drug that is legal under state law like medical
marijuana.109
There appears to be no legal consequence an employer can face for
accommodating an employee’s medical marijuana use other than the loss of federal
grants or contracts under the Drug Free Workplace Act. Consequently, the only
remaining barrier to accommodation is an employer’s concern for workplace safety.
Again, this issue can be addressed by creating a strict workplace policy that prohibits
employees from using medical marijuana on-the-job and by implementing a test for
impairment that would prevent employees from working while intoxicated. In fact,
every state that requires employers to accommodate an employee’s medical
marijuana use already has such prohibitions and protections written into their
statutes.110 Medical marijuana accommodation is viable so long as it is not abused,
and employees bear the responsibility of complying with the state Medical Cannabis
Program and an employer’s job performance standards.
III. CONCLUSION
A logical way forward for New Mexico
The New Mexico Court of Appeals cases finding medical marijuana to be
compensable under the Workers’ Compensation Act provide critical guidance for
106.
107.
108.
109.
110.

41 U.S.C. §§ 8102–03 (2011).
Id. § 8102.
Id. § 8102(A)–(C).
See id. § 8102(A).
See Deitchler, supra note 51.
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New Mexico’s future approach to medical marijuana and employment
discrimination. The Court of Appeals has set the precedent that medical marijuana is
not only compensable, but that it is a reasonable and necessary medical treatment,
and that a recommendation from a physician to the state’s Medical Cannabis
Program is the working equivalent of a prescription.
In keeping with the logic of these rulings, it follows that because many
medical marijuana patients have disabilities recognized under the New Mexico
Human Rights Act, the course of treatment must also be protected under the both the
plain language of the Act and the Court of Appeals’ decisions. This would entail
making employment decisions, including hiring decisions, based solely on an
employee’s qualifications and not on the employee’s medical status or positive drug
test indicating legal medical marijuana use. This approach would fulfill the intent of
the New Mexico Human Rights Act and the Lynn and Erin Compassionate Use Act
by allowing patients with serious illnesses to treat those illnesses with medical
marijuana and protect them from adverse employment actions based solely on that
use. It would also be consistent with the New Mexico Court of Appeals’ decisions
on medical marijuana, and provide protection for those who choose this reasonable,
necessary, and legal medical treatment option.
Accommodating an employee’s medical marijuana use would also exempt
employers from tolerating intoxicated employees or on-the-job use. An effective way
to simultaneously accommodate an employee’s use and address an employer’s
concern for workplace safety would be to implement a test measuring an employee’s
level of impairment rather than a standard drug test.111 A test for impairment would
be a cost-effective alternative to a traditional drug test and would prevent
discrimination based exclusively on medical marijuana use rather than safety or jobperformance.
The parameters of accommodation would be clearly delineated so that while
an employer cannot terminate an employee based only on medical marijuana use, the
employer has grounds to terminate an employee if the medical marijuana use
interferes with job-performance or workplace safety. Such an accommodation would
strike the balance between an employee’s privacy and right to choose to treat a
serious medical condition with medical marijuana, and an employer’s need to
maintain a safe work zone. Such an accommodation would also satisfy the intent of
the Lynn and Erin Compassionate Use Act and the New Mexico Human Rights Act,
and be consistent with the holdings of the New Mexico Court of Appeals workers’
compensation cases. Accommodating an employee’s medical marijuana use in this
way would account for the intent of the relevant state authorities and be a logical
way forward for New Mexico and New Mexican medical marijuana patients.

111. See Stacy A. Hickox, Drug Testing of Medical Marijuana Users in the Workplace: An Inaccurate
Test of Impairment, 29 HOFSTRA LAB. & EMP. L. J. 273 (2012).

